ProMIS Neurosciences is focused exclusively on treatments and cures for Alzheimer’s disease. Five million Americans are afflicted with the disease. Using our proprietary techniques we were able to identify toxic proteins and create five products that specifically target those toxic proteins.
We are at the stage where we validated the products and now we’re in the process of getting ready to scale them up for manufacturing and clinical development. It’s a major problem we have to address so we hope to be part of the solution.
For more information on ProMIS Neurosciences (PMN:TSX) or their treatment for Alzheimer’s, fill out the form below.